{"meta":{"query_hash":"41fdbd2dc2bc","filters":{"venue":"Drug Discovery Today Therapeutic Strategies"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/41fdbd2dc2bc","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drug+Discovery+Today+Therapeutic+Strategies"},"results":[{"id":"W1979457312","doi":"10.1016/j.ddstr.2013.11.001","title":"Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure","year":2012,"lang":"en","type":"review","venue":"Drug Discovery Today Therapeutic Strategies","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Heart and Stroke Foundation of Canada","keywords":"Angiotensin-converting enzyme 2; Heart failure; Angiotensin II; Angiotensin II receptor type 1; Pressure overload; Internal medicine; Receptor; Endocrinology; Renin–angiotensin system; Ventricular remodeling; Medicine; Muscle hypertrophy; Angiotensin-converting enzyme; Myocardial infarction; Angiotensin 1; Fibrosis; Blood pressure; Pharmacology; Cardiac hypertrophy; Disease","score_opus":0.05245593690220392,"score_gpt":0.3157799530829468,"score_spread":0.2633240161807429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979457312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021967514,0.99890316,0.00014877935,0.00016420429,0.00012165387,0.0000044830954,0.000012415358,0.000005685683,0.00041991522],"genre_scores_gemma":[0.0013187465,0.9976647,0.00024488408,0.00022993807,0.00018666933,0.000007018412,0.000020261325,0.0000010681127,0.0003268182],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987805,0.000020808611,0.000022375898,0.000022588436,0.000043962184,0.000012124782],"domain_scores_gemma":[0.9997372,0.00016392238,0.00003944325,0.0000058772935,0.00003599441,0.000017525284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058302,0.0009159789,0.0017445525,0.0013422539,0.00015519325,0.0007167954,0.00061461015,0.0007850013,0.0022194742],"category_scores_gemma":[0.0006468759,0.00025174543,0.0005302105,0.0010691494,0.00032725342,0.0009293137,0.0003993625,0.0015012881,0.0009017289],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000381302,0.0002081477,0.00024473292,0.022571318,0.00029907568,0.00034912073,0.000029752851,0.00032422465,0.004523022,0.0016478446,0.01600888,0.95341253],"study_design_scores_gemma":[0.00056321576,0.00094582065,0.0029426087,0.0069994833,0.0019429869,0.0032156918,0.00010833529,0.0005207747,0.0047422345,0.0038313041,0.974114,0.0000735663],"about_ca_topic_score_codex":0.0004346467,"about_ca_topic_score_gemma":0.0011918844,"teacher_disagreement_score":0.0022194742,"about_ca_system_score_codex":0.00028726214,"about_ca_system_score_gemma":0.00059892103,"threshold_uncertainty_score":0.007424891},"labels":[],"label_agreement":null},{"id":"W2055678521","doi":"10.1016/j.ddstr.2008.10.001","title":"Cognitive enhancing drugs for schizophrenia","year":2008,"lang":"en","type":"article","venue":"Drug Discovery Today Therapeutic Strategies","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Foothills Medical Centre","funders":"","keywords":"Schizophrenia (object-oriented programming); Cognition; Psychology; Dopamine; Dopamine hypothesis of schizophrenia; Neuroscience; Medicine; Psychiatry; Dopamine receptor D2","score_opus":0.01668047938715617,"score_gpt":0.26514548155943773,"score_spread":0.24846500217228157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055678521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13736752,0.70463675,0.00796451,0.029149394,0.0030465305,0.0001876658,0.0011942111,0.00074773584,0.11570577],"genre_scores_gemma":[0.4398916,0.4966671,0.006667521,0.007907497,0.0009862705,0.00013264398,0.0005051549,0.000051324037,0.047190923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99995685,0.00000947238,0.0000035866522,0.0000047278386,0.000014135236,0.000011150871],"domain_scores_gemma":[0.99994457,0.000011060023,0.000014588736,0.000003740974,0.000009418504,0.000016713679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019372009,0.0005361282,0.0003216542,0.0005277294,0.0003214062,0.00037108053,0.0003039603,0.0003836555,0.0051770406],"category_scores_gemma":[0.00016792728,0.000066228306,0.00025745525,0.00019978438,0.00043156734,0.0002509455,0.00037888324,0.0010627968,0.00105377],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017540223,0.0005166568,0.0008291683,0.0013574745,0.00008283649,0.0013987246,0.00014328827,0.00038650256,0.052992783,0.044809073,0.03438335,0.8613461],"study_design_scores_gemma":[0.0017227624,0.003227045,0.011194065,0.0008625679,0.0003991485,0.0055460506,0.0002819263,0.00086217915,0.04676041,0.0605984,0.86844033,0.00010514892],"about_ca_topic_score_codex":0.0016582806,"about_ca_topic_score_gemma":0.005229452,"teacher_disagreement_score":0.0051770406,"about_ca_system_score_codex":0.00054803584,"about_ca_system_score_gemma":0.00081709266,"threshold_uncertainty_score":0.017318964},"labels":[],"label_agreement":null},{"id":"W2066470480","doi":"10.1016/j.ddstr.2008.05.005","title":"Cardiovascular consequences of obesity","year":2008,"lang":"en","type":"article","venue":"Drug Discovery Today Therapeutic Strategies","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Obesity; Medicine; Diabetes mellitus; Disease; Body mass index; Metabolic syndrome; Obstructive sleep apnea; Sleep apnea; Type 2 diabetes; Developed country; Internal medicine; Environmental health; Endocrinology; Population","score_opus":0.024260419768501046,"score_gpt":0.248128240180448,"score_spread":0.22386782041194694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066470480","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55222243,0.32380986,0.0037723228,0.035959575,0.002899999,0.000054663466,0.0010308388,0.00011296308,0.08013728],"genre_scores_gemma":[0.89161396,0.0901293,0.0015308772,0.0041124234,0.0043809176,0.00003245008,0.00044497653,0.000012936167,0.007742162],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974304,0.00010780004,0.000012705867,0.000025442643,0.00006746006,0.00004354934],"domain_scores_gemma":[0.9997267,0.000074196076,0.00006530967,0.000028993045,0.000038072714,0.00006677351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041823677,0.00034624484,0.0003828824,0.00042512044,0.00027623714,0.0009557574,0.00018225917,0.00056821,0.001956948],"category_scores_gemma":[0.00070723007,0.00012821415,0.0003465561,0.00031859282,0.00035107342,0.00022725711,0.00033214258,0.0015286562,0.00021577325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071860845,0.0014457309,0.16514038,0.0015758395,0.0012712645,0.006906237,0.00037013236,0.001193112,0.07100844,0.048332956,0.02083526,0.6747346],"study_design_scores_gemma":[0.00033735606,0.0018733417,0.8616905,0.00063066155,0.0012159683,0.0085015055,0.00056164194,0.0010823485,0.006589982,0.046663035,0.07078647,0.00006718824],"about_ca_topic_score_codex":0.0010314166,"about_ca_topic_score_gemma":0.0017986824,"teacher_disagreement_score":0.001956948,"about_ca_system_score_codex":0.00027493262,"about_ca_system_score_gemma":0.00045678223,"threshold_uncertainty_score":0.0065466166},"labels":[],"label_agreement":null}]}